Directa Plus PLC Publication of peer reviewed scientific paper
12 Julio 2021 - 1:00AM
RNS Non-Regulatory
TIDMDCTA
Directa Plus PLC
12 July 2021
This is a Reach announcement and the information contained is
not considered to be material or to have a significant impact on
management's expectations of the Company's performance. Reach is an
investor communication service aimed at assisting listed and
unlisted (including AIM quoted) companies to distribute
non-regulatory news releases into the public domain. Information
required to be notified under the AIM Rules for Companies, Market
Abuse Regulation or other regulation would be disseminated as an
RNS regulatory announcement and not on Reach.
12 July 2021
Directa Plus plc
("Directa Plus" or the "Company")
Publication of Scientific Paper by Peer Reviewed Journal
iScience
Directa Plus (AIM: DCTA), a leading producer and supplier of
graphene nanoplatelets based products for use in consumer and
industrial markets, is pleased to announce that iScience has
published a scientific paper titled "Graphene Nanoplatelet and
Graphene Oxide Functionalization of Face Mask Materials Inhibits
Infectivity of Trapped SARS-CoV-2". iScience is a peer-reviewed
interdisciplinary open-access journal that publishes basic and
applied research that advances a specific field across the life,
physical, and earth sciences.
The paper provides scientific evidence that the Company's G+(R)
graphene nanomaterials and those from graphene oxide present a
critical opportunity to significantly increase face mask efficacy.
In relation to the anti-SARS CoV2 capability of Directa Plus' G+(R)
graphene, the paper certifies that G+(R) filter fabric treated with
PU G+(R) can inactivate 97% of the virus while G+(R) cotton can
inactivate 99% of the virus.
The Company's pristine G+(R) graphene is manufactured in a
sustainable manner, without the use of chemicals, by exploiting
water and mechanical treatment and is easily scalable. Combined
with a process yield of 100%, G+(R) graphene is perfectly aligned
to today's large supply chain needs. The production of graphene
oxide is significantly more complex and expensive, involving the
use of large amounts of chemicals. To date, the Company has treated
and supplied more than 240,000 meters of G+(R) graphene fabrics and
produced and delivered more than 1 million G+(R) filters to fight
the COVID-19 pandemic.
The antibacterial and antiviral properties of the Directa's
G+(R) pristine graphene nanoplatelets represent significant
opportunities for Directa Plus in textile and biomedical
applications. The efficacy of G+(R) and its non-toxic and
sustainable production characteristics overcome the problems of the
current state-of-the-art solutions that are based on metal-ion or
halogen treatments, which could be dangerous to human health and
detrimental to the environment.
Market demand for inherently antimicrobial (i.e. both
antibacterial and antiviral) surfaces and components is significant
and growing(1) . Directa Plus is working on a number of different
applications to exploit the antimicrobial properties of
G+(R)including apparel, upholstery and automotive applications, as
well as composite and biomedical materials.
(1) See for example
https://www.marketdataforecast.com/market-reports/antimicrobial-coatings-market
and Antimicrobial Coatings Market Size and Share | Industry
Forecast - 2026 (gminsights.com)
The paper is available at
https://www.cell.com/iscience/fulltext/S2589-0042(21)00756-2 . The
authors include Massimiliano Papi and Valentina Palmieri (Catholic
University Rome), Flavio De Maio and Gabriele Babini (Gemelli
Polyclinic Rome) Laura Rizzi and Giulio Cesareo (Directa Plus) and,
Patrick Soon-Shiong and Patricia Spilman (Nantworks).
Commenting on the paper, Giulio Cesareo, Founder and CEO of
Directa Plus said: "Science underpins all of our work on
applications, as this peer reviewed paper demonstrates. Our mission
in this market is to offer customers the widest possible protection
and we are already working on testing other types of bacteria and
viruses to achieve that goal."
For further information please visit
http://www.directa-plus.com/ or contact:
Directa Plus plc +39 02 36714458
Giulio Cesareo, CEO
Giorgio Bonfanti, CFO
Cenkos Securities plc (Nominated Adviser
and Joint Broker) +44 131 220 6939
Neil McDonald
Pete Lynch
N+1 Singer (Joint Broker) +44 20 7496 3069
Rick Thompson
Phil Davies
Tavistock (Financial PR and IR) +44 20 7920 3150
Simon Hudson
Heather Armstrong
About Directa Plus
Our focus is principally on the two sectors in which we have
strong commercial advantage through developed and launched products
and a technological lead: environmental (based on our
Grafysorber(R) product), textiles (based on our G+(R) products)
and, more recently, lithium-sulphur batteries. In addition, we will
continue to pursue opportunities in elastomers and composites
(including tyres and asphalt), also using our G+(R) products. All
our products are hypoallergenic, non-toxic and sustainably
produced.
-ends-
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUAVVRANUBAAR
(END) Dow Jones Newswires
July 12, 2021 02:00 ET (06:00 GMT)
Directa Plus (LSE:DCTA)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Directa Plus (LSE:DCTA)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024